Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Asset Utilization Ratio: 2011-2025

Historic Asset Utilization Ratio for Ani Pharmaceuticals (ANIP) over the last 14 years, with Sep 2025 value amounting to 0.60.

  • Ani Pharmaceuticals' Asset Utilization Ratio rose 19.48% to 0.60 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.60, marking a year-over-year increase of 19.48%. This contributed to the annual value of 0.56 for FY2024, which is 4.00% down from last year.
  • As of Q3 2025, Ani Pharmaceuticals' Asset Utilization Ratio stood at 0.60, which was up 5.98% from 0.57 recorded in Q2 2025.
  • Ani Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.60 during Q3 2025, with a 5-year trough of 0.28 in Q4 2021.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.52 (2025), whereas its average is 0.53.
  • As far as peak fluctuations go, Ani Pharmaceuticals' Asset Utilization Ratio slumped by 38.35% in 2021, and later surged by 57.73% in 2023.
  • Ani Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.28 in 2021, then soared by 51.68% to 0.42 in 2022, then climbed by 28.56% to 0.54 in 2023, then fell by 11.92% to 0.48 in 2024, then rose by 19.48% to 0.60 in 2025.
  • Its Asset Utilization Ratio stands at 0.60 for Q3 2025, versus 0.57 for Q2 2025 and 0.52 for Q1 2025.